Beijing LabTech Instruments (688056): Continuous expansion of instrument product lines with optimized gross margin.

This report introduction: the improvement of product gross margin combined with optimized cost control leads to significant year-on-year growth in performance. Continuous development of domestic alternatives for scientific instruments and core components, actively expanding applications in emerging fields. Investment highlights: maintaining a "Shareholding" rating. We maintain.

GUOTAI HAITONG SECApr 26 00:00

Beijing LabTech Instruments' net profit in 2024 increased by more than 30% year-on-year, with some fundraising investment projects postponed.

1. Beijing LabTech Instruments stated that the main reason for the increase in net income is that raw material costs have basically stabilized, and the overall gross margin for the year is stable and has also rebounded; 2. During the reporting period, revenue from Beijing LabTech Instruments' Semiconductors business was 16.8051 million yuan, with operating income decreasing by 33.47% compared to the same period last year.

cls.cnApr 25 08:00

Libertec: 2024 Annual Report

SZSIApr 25 00:00 · Announcements

Libertech: 2024 Annual Report Summary

SZSIApr 25 00:00 · Announcements

Libertech: First quarter report 2025

SZSIApr 25 00:00 · Announcements

2025 First Quarter Report

SZSIApr 25 00:00 · Announcements